Masaki, Yasufumi http://orcid.org/0000-0002-5658-3765
,
Kawabata, Hiroshi
Takai, Kazue
Tsukamoto, Norifumi
Fujimoto, Shino
Ishigaki, Yasuhito
Kurose, Nozomu
Miura, Katsuhiro
Nakamura, Shigeo
Aoki, Sadao
Funding for this research was provided by:
Ministry of Health, Labour and Welfare (H29 Nanchi, etc. (Nan)-General-019, H27-28 Nanchi, etc. (Nan)-General-008, H27-28 Nanchi, etc. (Nan)-General-002)
Article History
Received: 9 September 2019
Revised: 5 November 2019
Accepted: 7 November 2019
First Online: 28 November 2019
Compliance with ethical standards
:
: YM has received research grants from Kyowa Hakko Kirin Pharma, Astellas Pharma, Eisai Pharma, Ono Pharma, Pfizer Pharma, Asahi Kasei Pharma, MSD Pharma, Daiichi-Sankyo Pharma, Taisho Pharma, Taiho Pharma, Takeda Pharma, Chugai Pharma, Teijin Pharma, Nippon Kayaku, and Mochida Pharma, outside the submitted work. All other authors have no conflicts of interest.